Table 5. Secondary outcome over 24 month period.
CsAM (N = 191) | TacM (N = 167) | P value | |
---|---|---|---|
Death, n (%) | 15 (7.9) | 9 (5.4) | 0.35 |
Graft loss, n (%) | 14 (7.3) | 12 (7.2) | 0.96 |
BPAR, n (%) | 38 (19.9) | 18 (10.8) | 0.02 |
Chi-square test was used for the efficacy related results over 24 months between the treatment groups. CsA: cyclosporine A with or without prednisone and MPS or MMF, Tac: tacrolimus with or without prednisone and MPS or MMF.